Journal of Cardiothoracic and Vascular Anesthesia
Volume 24, Issue 2 , Pages 239-243 , April 2010

Amiodarone for the Prevention of Reperfusion Ventricular Fibrillation

  • Aloka Samantaray, MD, PDCC

      Affiliations

    • Department of Anesthesiology and Critical Care, Sri Venkateswara Institute of Medical Sciences, Andhra Pradesh, India
    • Corresponding Author InformationAddress reprint requests to Aloka Samantaray, MD, PDCC, Department of Anesthesiology and Critical Care, Sri Venkateswara Institute of Medical Sciences, SVIMS University, Tirupati, Andhra Pradesh 517507, India
    • ,
  • Abha Chandra, MS, MCh

      Affiliations

    • Department of Cardiovascular-Thoracic Surgery, Sri Venkateswara Institute of Medical Sciences, Andhra Pradesh, India
    • ,
  • Sanjukta Panigrahi, MD, PDCC

      Affiliations

    • Department of Anesthesiology and Critical Care, Sri Venkateswara Institute of Medical Sciences, Andhra Pradesh, India

References 

  1. Praeger PI, Kay RH, Moggio R, et al. Prevention of ventricular fibrillation after aortic declamping during cardiac Surgery. Tex Heart Inst J. 1988;15:98–101
  2. Sellevold OF, Berg EM, Levang OW. Procaine is effective for minimizing postischemic ventricular fibrillation in cardiac surgery. Anesth Analg. 1995;81:932–938
  3. Lu HR, Yang P, Remeysen P, et al. Ischemia/ reperfusion induced arrhythmias in anaesthetized rats: A role of Na+ and Ca2+ influx. Eur J Pharmacol. 1999;365:233–239
  4. Doherty PW, McLaughlin PR, Billingham M, et al. Cardiac damage produced by direct current countershock applied to the heart. Am J Cardiol. 1979;43:225
  5. Vaughan Williams EM. A classification of antiarrhythmic agents reassessed after a decade of new drugs. J Clin Pharmacol. 1984;24:129
  6. Tiryakioglu O, Demirtas S, Ari H, et al. Magnesium sulphate and amiodarone prophylaxis for prevention of postoperative arrhythmia in coronary bypass operations. J Cardiothorac Surg. 2009;4:8
  7. Boudewijn PJ, Leeuwenburgh Michael, Versteegh IM, et al. Should amiodarone or lidocaine be given to patients who arrest after cardiac surgery and fail to cardiovert from ventricular fibrillation?. Interact CardioVasc Thorac Surg. 2008;7:1148-115
  8. Guidelines 2000 for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care: An international consensus on science (6. Advanced cardiovascular life support). Circulation. 2000;102(suppl 8):I105–I111
  9. Singh BN. Initial antiarrhythmic drug therapy during resuscitation from sudden cardiac death: A time for a fundamental change in strategy?. J Cardiovasc Pharmacol Ther. 2000;5:3–9
  10. Singh BN. Routine prophylactic lidocaine administration in acute myocardial infarction (An idea whose time is all but gone?). Circulation. 1992;86:1033–1035
  11. Dorian P, Cass D, Schwartz B, et al. Amiodarone as compared with lidocaine for shock-resistant ventricular fibrillation. N Engl J Med. 2002;346:884–890
  12. Parratt JR. Inhibitors of the slow calcium current and early ventricular arrhythmias. In:  Parratt JR editors. Early Arrhythmias Resulting From Myocardial Ischaemia. London: Macmillan; 1982;p. 329–346
  13. He ZS, Komori S, Tamura K, et al. Inhibitory effect of moricizine on reperfusion induced tachyarrhythmias in rats (A comparison study with disopyramide and mexiletine). Jpn Circ J. 1992;56:861–865
  14. Corr PB, Pogwizd SM. Mechanisms contributing to arrhythmogenesis during early myocardial ischemia, subsequent reperfusion, and chronic infarction. Angiology. 1988;39:684–699
  15. Komori S, Sano S, Li BH, et al. Effects of bidisommide (SC-40230), a new class I antiarrhythmic agent, on ventricular arrhythmias induced by coronary artery occlusion and reperfusion in anesthetized rats; comparison with mexiletine and disopyramide. Heart Vessels. 1995;10:7–11
  16. Janse MJ, Capelle FJL, van Morsink H, et al. Flow of injury current and patterns of excitation during early ventricular arrhythmias in acute regional myocardial ischemia in isolated porcine and canine hearts. Circ Res. 1980;47:151–165
  17. Connolly SJ. Evidence-based analysis of amiodarone efficacy and safety. Circulation. 1999;100:2025
  18. Kodama I, Kamiya K, Toyama J. Cellular electropharmacology of amiodarone. Cardiovasc Res. 1997;35:13–29
  19. Watanabe Y, Kimura J. Inhibitory effect of amiodarone on Na+/Ca2+ exchange current in guinea pig cardiac myocytes. Br J Pharmacol. 2000;131:80–84
  20. Moreau D, Clauw F, Martine L, et al. Effects of amiodarone on cardiac function and mitochondrial oxidative phosphorylation during ischemia and reperfusion. Mol Cell Biochem. 1999;194:291–300
  21. Varbiro G, Toth A, Tapodi A, et al. Protective effect of amiodarone but not N-desethylamiodarone on postischemic hearts through the inhibition of mitochondrial permeability transition. J Pharmacol Exp Ther. 2003;307:615–625
  22. Ide T, Tsutsui H, Kinugawa S, et al. Amiodarone protects cardiac myocytes against oxidative injury by its free radical scavenging action. Circulation. 1999;100:690–692
  23. You B, Pu J, Liu N, et al. Effect of lidocaine and amiodarone on transmural heterogeneity of ventricular repolarization in isolated rabbit heart model of sustained global ischemia. J Huazhong Univ Sci Technolog Med Sci. 2005;25:400–403
  24. Rady MY, Ryan T, Starr NJ. Preoperative therapy with amiodarone and the incidence of acute organ dysfunction after cardiac surgery. Anesth Analg. 1997;85:489
  25. Kupferschmid JP, Rosengart TK, McIntosh CL, et al. Amiodarone-induced complications after cardiac operation for obstructive hypertrophic cardiomyopathy. Ann Thorac Surg. 1989;48:359
  26. Dorge H, Schoendube FA, Schoberer M, et al. Intraoperative amiodarone as prophylaxis against atrial fibrillation after coronary operations. Ann Thorac Surg. 2000;69:1358
  27. Lee SH, Chang CM, Lu MJ, et al. Intravenous amiodarone for prevention of atrial fibrillation after coronary artery bypass grafting. Ann Thorac Surg. 2000;70:157
  28. Argyriou M, Hountis P, Antonopoulos N, et al. Acute fatal post-CABG low dose amiodarone lung toxicity. Asian Cardiovasc Thorac Ann. 2007;15:e66–e68
  29. Handschin AE, Lardinois D, Schneiter D, et al. Acute amiodarone-induced pulmonary toxicity following lung resection. Respiration. 2003;70:310–312
  30. Doenst T, Wijeysundera D, Karkouti K, et al. Hyperglycemia during cardiopulmonary bypass is an independent risk factor for mortality in patients undergoing cardiac surgery. J Thorac Cardiovasc Surg. 2005;130:1144–1150
  31. Gandhi GY, Nuttall GA, Abel MD, et al. Intraoperative hyperglycemia and perioperative outcomes in cardiac surgery patients. Mayo Clin Proc. 2005;80:862–866

PII: S1053-0770(09)00285-7

doi: 10.1053/j.jvca.2009.07.007

Journal of Cardiothoracic and Vascular Anesthesia
Volume 24, Issue 2 , Pages 239-243 , April 2010

Article Tools

* Image Usage & Resolution